155 related articles for article (PubMed ID: 27836543)
1. miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis.
Song C; Lu P; Sun G; Yang L; Wang Z; Wang Z
Biochem Biophys Res Commun; 2017 Jan; 482(1):22-27. PubMed ID: 27836543
[TBL] [Abstract][Full Text] [Related]
2. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
Wang X; Dong K; Gao P; Long M; Lin F; Weng Y; Ouyang Y; Ren J; Zhang H
Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
4. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
Li QC; Xu H; Wang X; Wang T; Wu J
Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
[TBL] [Abstract][Full Text] [Related]
5. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
6. PDL1 Regulation by p53 via miR-34.
Cortez MA; Ivan C; Valdecanas D; Wang X; Peltier HJ; Ye Y; Araujo L; Carbone DP; Shilo K; Giri DK; Kelnar K; Martin D; Komaki R; Gomez DR; Krishnan S; Calin GA; Bader AG; Welsh JW
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26577528
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
8. miR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathway.
Zhang S; Zhang C; Li Y; Wang P; Yue Z; Xie S
Biomed Pharmacother; 2011 Sep; 65(6):436-42. PubMed ID: 21880462
[TBL] [Abstract][Full Text] [Related]
9. Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells.
Chakraborty S; Mazumdar M; Mukherjee S; Bhattacharjee P; Adhikary A; Manna A; Chakraborty S; Khan P; Sen A; Das T
FEBS Lett; 2014 Feb; 588(4):549-59. PubMed ID: 24444609
[TBL] [Abstract][Full Text] [Related]
10. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis.
Ramaiah MJ; Pushpavalli SN; Lavanya A; Bhadra K; Haritha V; Patel N; Tamboli JR; Kamal A; Bhadra U; Pal-Bhadra M
Bioorg Med Chem Lett; 2013 Oct; 23(20):5699-706. PubMed ID: 23992861
[TBL] [Abstract][Full Text] [Related]
11. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1.
Cheng D; Xu Y; Sun C; He Z
Mol Cell Biochem; 2016 Dec; 423(1-2):85-91. PubMed ID: 27686452
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Action of 1,2-Epoxy-3 (3- (3,4-dimethoxyphenyl)- 4H-1-benzopiyran-4-on) Propane with Doxorubicin and Cisplatin through Increasing of p53, TIMP-3, and MicroRNA-34a in Cervical Cancer Cell Line (HeLa).
Yuniarti L; Mustofa M; Aryandono T; Haryana SM
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2955-2962. PubMed ID: 30362332
[TBL] [Abstract][Full Text] [Related]
14. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 Polyunsaturated Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid Enhance Dexamethasone Sensitivity in Multiple Myeloma Cells by the p53/miR-34a/Bcl-2 Axis.
Dai X; Li M; Geng F
Biochemistry (Mosc); 2017 Jul; 82(7):826-833. PubMed ID: 28918747
[TBL] [Abstract][Full Text] [Related]
16. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.
Weeraratne SD; Amani V; Neiss A; Teider N; Scott DK; Pomeroy SL; Cho YJ
Neuro Oncol; 2011 Feb; 13(2):165-75. PubMed ID: 21177782
[TBL] [Abstract][Full Text] [Related]
17. MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.
Zheng G; Li N; Jia X; Peng C; Luo L; Deng Y; Yin J; Song Y; Liu H; Lu M; Zhang Z; Gu Y; He Z
J Mol Med (Berl); 2016 Oct; 94(10):1129-1141. PubMed ID: 27055844
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53/miR-34a axis.
Zhou B; Yi H; Tan J; Wu Y; Liu G; Qiu Z
Phytother Res; 2015 Mar; 29(3):415-22. PubMed ID: 25572695
[TBL] [Abstract][Full Text] [Related]
19. MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.
Lai M; Du G; Shi R; Yao J; Yang G; Wei Y; Zhang D; Xu Z; Zhang R; Li Y; Li Z; Wang L
Mol Med Rep; 2015 May; 11(5):3301-7. PubMed ID: 25585539
[TBL] [Abstract][Full Text] [Related]
20. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
